Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
15 Results Found
Associate Podcast Series - Ep. 88 | Healthcare Linen Services Group
In this episode, Kathleen Wessel, vice president of business management and operations at the American Hospital Association is joined by Adam Buol, vice president of corporate accounts at Healthcare Linen Services Group. They will discuss how the consolidation of suppliers can offer strategic and operational advantages in addition to significant cost savings. Tune in to hear real-world examples of how working with fewer suppliers affects vendor relationships — both positively and negatively.
FDA announces end to IV saline solution shortage
The Food and Drug Administration Aug. 8 announced an end to the national shortage of sodium chloride 0.9% IV solutions products.
Health Care Supply Chain Strategies
Increased supply chain challenges and mergers and acquisitions require sound strategy to capitalize on opportunities. Here’s how to do it.
Baxter increases allocations of two IV solutions to 100%
Baxter notified customers on Jan. 22 that allocations for two sodium chloride IV solutions have been increased to 100%. According to Baxter, the products will have a one- to two-week lag time while they progress through the full distribution network.
8 of 10 Baxter manufacturing lines restarted
After incurring damage from Hurricane Helene on Sept. 27, Baxter reports that as of Dec. 19, nearly all of its manufacturing lines in its North Cove, N.C., facility have been restarted.
Baxter restores additional IV solutions production lines
Baxter has resumed production on all of its 3-liter irrigation and peritoneal dialysis solutions manufacturing lines, the company announced Dec. 5.
FDA says shortage of empty IV bags expected to last through March
The Food and Drug Administration Dec. 4 announced empty IV bags have been added to its Medical Device Shortages List, and that the shortage is estimated to last through March.
Baxter announces increased allocations for certain IV products
Baxter Nov. 26 announced new allocation levels for multiple IV product groups and advised customers of a one- to two-week lead time for products to flow through its supply and distribution network.
Baxter restarts busiest IV solutions manufacturing line
Baxter announced Oct. 31 that it has restarted the highest-throughput IV solutions manufacturing line at its North Cove, N.C. facility, which normally accounts for nearly 25% of the site's total production and approximately 50% of its one-liter IV solutions — the most commonly used size by hospitals and clinics.
Group says medical radioisotope supply to return to normal week of Nov. 11
Supplies of Mo-99/Tc-99M, which are medical radioisotopes used in procedures to diagnose and detect diseases including heart disease and cancer, are anticipated to return to normal the week of Nov. 11, according to Nuclear Medicine Europe.